Irinotecan: all 829 studies that test it

Page 8 of 9. Open to participants first (121), then studies with results posted, then the rest; newest registration first within each.

• Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid TumorsCompletedNCT00074321Phase 1
• Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073866Phase 1/2
• Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineCompletedNCT00072852Phase 2
• Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00072527Phase 2
• S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumWithdrawnNCT00070434Phase 2
• S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyCompletedNCT00066612Phase 2
• Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile CancerCompletedNCT00066391Phase 2
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerCompletedNCT00066274Phase 2
• Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal CancerCompletedNCT00064181Phase 3
• Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal CancerCompletedNCT00063960Phase 2
• Study of Irinotecan on a Weekly Schedule in ChildrenCompletedNCT00062842Phase 1
• Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00062322Phase 1
• Irinotecan and Thalidomide in Treating Patients With Advanced Solid TumorsCompletedNCT00062127Phase 1
• Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00059761Phase 1
• A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid TumorsCompletedNCT00057473Phase 2
• Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid TumorsCompletedNCT00054288Phase 1
• S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerTerminatedNCT00053833Phase 2
• Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous LeukemiaCompletedNCT00053144Phase 1
• Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerTerminatedNCT00052585Phase 2
• Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00052494Phase 1
• A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00048139Phase 2
• A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00048126Phase 2
• UCN-01 and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00047242Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00046917Phase 1
• Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00045604Phase 1
• Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid TumorsActive, not recruitingNCT00045201Phase 1
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00042874Phase 1
• Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerCompletedNCT00040807Phase 2
• A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal CancerTerminatedNCT00040391Phase 2
• Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation TherapyCompletedNCT00039468Phase 2
• Combination Chemotherapy in Treating Patients With Colorectal CancerCompletedNCT00039208Phase 2
• Irinotecan in Treating Patients With Refractory Solid Tumors and Liver DysfunctionCompletedNCT00037804Phase 1
• A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.CompletedNCT00034502Phase 1/2
• BMS-247550 in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00033306Phase 2
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusCompletedNCT00030862Phase 2
• Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00030797Phase 2
• Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the LiverCompletedNCT00030563Phase 2
• S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00030433Phase 2
• Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma MultiformeCompletedNCT00027612Phase 1/2
• ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal CancerCompletedNCT00026364Phase 1
• Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal CancerCompletedNCT00026273Phase 3
• Irinotecan in Treating Aging Patients With Solid TumorsCompletedNCT00026195Phase 1
• Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaCompletedNCT00025363Phase 2
• Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00025285Phase 2
• Carboplatin and Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00024284Phase 1
• Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid TumorsCompletedNCT00024141Phase 1
• Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00022308Phase 1
• Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00021281Phase 3
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00021073Phase 1
• Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal CancerCompletedNCT00020917Phase 2
• Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or StomachCompletedNCT00020761Phase 2
• Epirubicin Plus Irinotecan in Treating Patients With Advanced CancerCompletedNCT00020748Phase 1
• Combination Chemotherapy in Treating Patients Who Have Advanced Solid TumorsCompletedNCT00020488Phase 1
• Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00016952Phase 2
• Irinotecan in Treating Children With Refractory or Progressive Solid TumorsCompletedNCT00016861Phase 1
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerCompletedNCT00012389Phase 3
• S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusCompletedNCT00012363Phase 2
• Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the PancreasCompletedNCT00012220Phase 2
• Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma MultiformeCompletedNCT00010036Phase 2
• Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving AnticonvulsantsCompletedNCT00008424Phase 1
• Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal CancerCompletedNCT00008060Phase 3
• Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal CancerCompletedNCT00006786Phase 2
• Flavopiridol and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00006485Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00006465Phase 1
• Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon CancerTerminatedNCT00006269Phase 3
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00006115Phase 2
• Combination Chemotherapy in Treating Patients With Colorectal CancerCompletedNCT00006103Phase 3
• Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00006095Phase 1
• Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006025Phase 1
• SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00006000Phase 1
• Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon CancerCompletedNCT00005979Phase 3
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung CancerCompletedNCT00005972Phase 2
• Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant GliomaCompletedNCT00005951Phase 1
• SU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerCompletedNCT00005818Phase 1/2
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00005791Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerCompletedNCT00005638Phase 1
• Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)CompletedNCT00005626Phase 2
• Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal CancerCompletedNCT00005076Phase 2
• Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00005036Phase 3
• Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00004924Phase 2
• Docetaxel and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00004923Phase 1/2
• Irinotecan in Treating Patients With Advanced Neuroendocrine TumorsCompletedNCT00004922Phase 2
• Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004919Phase 1
• Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal CancerCompletedNCT00004885Phase 3
• Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00004870Phase 1/2
• Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or StomachCompletedNCT00004235Phase 2
• Irinotecan in Treating Patients With Metastatic or Recurrent Breast CancerCompletedNCT00004182Phase 2
• Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00004139Phase 2
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00004095Phase 1
• Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2
• Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain TumorCompletedNCT00004068Phase 2
• Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00004051Phase 1
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary OriginCompletedNCT00004005Phase 2
• Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaCompletedNCT00003970Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or SarcomaCompletedNCT00003955Phase 2
• Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal CancerCompletedNCT00003950Phase 2
• Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerCompletedNCT00003900Phase 2
• Irinotecan and Capecitabine in Treating Patients With Solid TumorsCompletedNCT00003867Phase 1
• Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00003753Phase 2

← Irinotecan overview